Atai Life Sciences Profit Margin 2020-2025 | ATAI

Current and historical gross margin, operating margin and net profit margin for Atai Life Sciences (ATAI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Atai Life Sciences net profit margin as of March 31, 2025 is 0%.
Atai Life Sciences Annual Profit Margins
Atai Life Sciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.497B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.031B 19.74
Encompass Health (EHC) United States $12.013B 25.47
DaVita (DVA) United States $10.339B 14.54
Chemed (CHE) United States $8.026B 25.23
Elanco Animal Health (ELAN) United States $6.685B 14.32
Option Care Health (OPCH) United States $5.163B 23.01
RadNet (RDNT) United States $4.144B 263.00
Amedisys (AMED) United States $3.199B 21.51
Addus HomeCare (ADUS) United States $2.094B 22.99
LifeStance Health (LFST) United States $1.878B 0.00
Astrana Health (ASTH) United States $1.345B 33.33
U.S Physical Therapy (USPH) United States $1.128B 29.13
Pennant (PNTG) United States $0.958B 35.17
Aveanna Healthcare Holdings (AVAH) United States $0.921B 52.44
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.042B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00